Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Cancer Drug Therapy industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Amgen / Allergan
Pfizer
AstraZeneca
Incyte
Roche
Bristol-Myers Squibb
Exelixis
Aveo Pharmaceuticals
Novartis
Bayer
Merck
Argos Therapeutics
Genentech (Roche)
By Type:
Chemotherapy
Immunotherapy
Targeted Therapy
By Application:
Angiogenesis Inhibitors
mTOR Inhibitors
Cytokine Immunotherapy (IL-2)
Monoclonal Antibodies
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Cancer Drug Therapy Market Overview 2018-2029
-
1.1 China Cancer Drug Therapy Industry Development Overview
-
1.2 China Cancer Drug Therapy Industry Development History
-
1.3 China Cancer Drug Therapy Industry Market Size (2018-2029)
-
1.4 China Cancer Drug Therapy Market Analysis by Type from Production Side
-
1.4.1 China Cancer Drug Therapy Production Volume, Production Value and Growth Rate of Chemotherapy (2018-2029)
-
1.4.2 China Cancer Drug Therapy Production Volume, Production Value and Growth Rate of Immunotherapy (2018-2029)
-
1.4.3 China Cancer Drug Therapy Production Volume, Production Value and Growth Rate of Targeted Therapy (2018-2029)
-
1.5 China Cancer Drug Therapy Market Analysis by Application from Consumption End
-
1.5.1 China Cancer Drug Therapy Sales Volume, Sales Value and Growth Rate of Angiogenesis Inhibitors (2018-2029)
-
1.5.2 China Cancer Drug Therapy Sales Volume, Sales Value and Growth Rate of mTOR Inhibitors (2018-2029)
-
1.5.3 China Cancer Drug Therapy Sales Volume, Sales Value and Growth Rate of Cytokine Immunotherapy (IL-2) (2018-2029)
-
1.5.4 China Cancer Drug Therapy Sales Volume, Sales Value and Growth Rate of Monoclonal Antibodies (2018-2029)
-
1.6 China Cancer Drug Therapy Market Analysis by Region
-
1.6.1 North China Cancer Drug Therapy Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Cancer Drug Therapy Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Cancer Drug Therapy Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Cancer Drug Therapy Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Cancer Drug Therapy Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Cancer Drug Therapy Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Cancer Drug Therapy Market Size and Growth Rate from 2018-2029
Chapter 2 China Cancer Drug Therapy Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Cancer Drug Therapy Market Status and Competition at home and abroad in 2023
-
2.2.2 China Cancer Drug Therapy Market Status and Competition Analysis in 2023
-
2.2.3 China Cancer Drug Therapy Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Cancer Drug Therapy Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Cancer Drug Therapy Industry Development
Chapter 3 Cancer Drug TherapyIndustry Chain Analysis
-
3.1 Cancer Drug Therapy Industry Chain
-
3.2 Cancer Drug Therapy Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Cancer Drug Therapy Market
-
3.3 Cancer Drug Therapy Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Cancer Drug Therapy Market
Chapter 4 China Cancer Drug Therapy Market, by Type
-
4.1 China Cancer Drug Therapy Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Cancer Drug Therapy Total Production Volume and Growth Rate from Production Side
-
4.5 China Cancer Drug Therapy Production Volume and Growth Rate, by Type
-
4.5.1 China Cancer Drug Therapy Production Volume and Growth Rate of Chemotherapy
-
4.5.2 China Cancer Drug Therapy Production Volume and Growth Rate of Immunotherapy
-
4.5.3 China Cancer Drug Therapy Production Volume and Growth Rate of Targeted Therapy
Chapter 5 China Cancer Drug Therapy Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Cancer Drug Therapy Total Market Size and Growth Rate from Consumption End
-
5.5 China Cancer Drug Therapy Market Size and Growth Rate, by Application
-
5.5.1 China Cancer Drug Therapy Market Size and Growth Rate of Angiogenesis Inhibitors
-
5.5.2 China Cancer Drug Therapy Market Size and Growth Rate of mTOR Inhibitors
-
5.5.3 China Cancer Drug Therapy Market Size and Growth Rate of Cytokine Immunotherapy (IL-2)
-
5.5.4 China Cancer Drug Therapy Market Size and Growth Rate of Monoclonal Antibodies
Chapter 6 China Cancer Drug Therapy Market, by Region
-
6.1 China Cancer Drug Therapy Production Volume and Production Value, by Region
-
6.2 China Cancer Drug Therapy Sales Volume and Sales Value, by Region
Chapter 7 North China Cancer Drug Therapy Market Analysis
-
7.1 North China Cancer Drug Therapy Market, by Type
-
7.2 North China Cancer Drug Therapy Market, by Application
Chapter 8 Central China Cancer Drug Therapy Market Analysis
-
8.1 Central China Cancer Drug Therapy Market, by Type
-
8.2 Central China Cancer Drug Therapy Market, by Application
Chapter 9 South China Cancer Drug Therapy Market Analysis
-
9.1 South China Cancer Drug Therapy Market, by Type
-
9.2 South China Cancer Drug Therapy Market, by Application
Chapter 10 East China Cancer Drug Therapy Market Analysis
-
10.1 East China Cancer Drug Therapy Market, by Type
-
10.2 East China Cancer Drug Therapy Market, by Application
Chapter 11 Northeast China Cancer Drug Therapy Market Analysis
-
11.1 Northeast China Cancer Drug Therapy Market, by Type
-
11.2 Northeast China Cancer Drug Therapy Market, by Application
Chapter 12 Southwest China Cancer Drug Therapy Market Analysis
-
12.1 Southwest China Cancer Drug Therapy Market, by Type
-
12.2 Southwest China Cancer Drug Therapy Market, by Application
Chapter 13 Northwest China Cancer Drug Therapy Market Analysis
-
13.1 Northwest China Cancer Drug Therapy Market, by Type
-
13.2 Northwest China Cancer Drug Therapy Market, by Application
Chapter 14 Company Profiles
-
14.1 Amgen / Allergan
-
14.1.1 Amgen / Allergan Company Profile
-
14.1.2 Amgen / Allergan Cancer Drug Therapy Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Pfizer
-
14.2.1 Pfizer Company Profile
-
14.2.2 Pfizer Cancer Drug Therapy Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 AstraZeneca
-
14.3.1 AstraZeneca Company Profile
-
14.3.2 AstraZeneca Cancer Drug Therapy Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Incyte
-
14.4.1 Incyte Company Profile
-
14.4.2 Incyte Cancer Drug Therapy Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Roche
-
14.5.1 Roche Company Profile
-
14.5.2 Roche Cancer Drug Therapy Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Bristol-Myers Squibb
-
14.6.1 Bristol-Myers Squibb Company Profile
-
14.6.2 Bristol-Myers Squibb Cancer Drug Therapy Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Exelixis
-
14.7.1 Exelixis Company Profile
-
14.7.2 Exelixis Cancer Drug Therapy Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Aveo Pharmaceuticals
-
14.8.1 Aveo Pharmaceuticals Company Profile
-
14.8.2 Aveo Pharmaceuticals Cancer Drug Therapy Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Novartis
-
14.9.1 Novartis Company Profile
-
14.9.2 Novartis Cancer Drug Therapy Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Bayer
-
14.10.1 Bayer Company Profile
-
14.10.2 Bayer Cancer Drug Therapy Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Merck
-
14.11.1 Merck Company Profile
-
14.11.2 Merck Cancer Drug Therapy Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Argos Therapeutics
-
14.12.1 Argos Therapeutics Company Profile
-
14.12.2 Argos Therapeutics Cancer Drug Therapy Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 Genentech (Roche)
-
14.13.1 Genentech (Roche) Company Profile
-
14.13.2 Genentech (Roche) Cancer Drug Therapy Market Performance
-
14.13.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Cancer Drug Therapy Industry Research Conclusions
-
15.2 Cancer Drug Therapy Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Cancer Drug Therapy Industry Market Size (2018-2029)
-
Figure China Cancer Drug Therapy Production Volume, Production Value and Growth Rate of Chemotherapy (2018-2029)
-
Figure China Cancer Drug Therapy Production Volume, Production Value and Growth Rate of Immunotherapy (2018-2029)
-
Figure China Cancer Drug Therapy Production Volume, Production Value and Growth Rate of Targeted Therapy (2018-2029)
-
Figure China Cancer Drug Therapy Sales Volume, Sales Value and Growth Rate of Angiogenesis Inhibitors (2018-2029)
-
Figure China Cancer Drug Therapy Sales Volume, Sales Value and Growth Rate of mTOR Inhibitors (2018-2029)
-
Figure China Cancer Drug Therapy Sales Volume, Sales Value and Growth Rate of Cytokine Immunotherapy (IL-2) (2018-2029)
-
Figure China Cancer Drug Therapy Sales Volume, Sales Value and Growth Rate of Monoclonal Antibodies (2018-2029)
-
Figure North China Cancer Drug Therapy Market Size and Growth Rate from 2018-2029
-
Figure Central China Cancer Drug Therapy Market Size and Growth Rate from 2018-2029
-
Figure South China Cancer Drug Therapy Market Size and Growth Rate from 2018-2029
-
Figure East China Cancer Drug Therapy Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Cancer Drug Therapy Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Cancer Drug Therapy Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Cancer Drug Therapy Market Size and Growth Rate from 2018-2029
-
Figure Cancer Drug Therapy Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Cancer Drug Therapy Market Share by Type in 2018
-
Figure China Cancer Drug Therapy Market Share by Type in 2023
-
Figure China Cancer Drug Therapy Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Cancer Drug Therapy Production Volume and Growth Rate of Chemotherapy (2018-2023)
-
Figure China Cancer Drug Therapy Production Volume and Growth Rate of Immunotherapy (2018-2023)
-
Figure China Cancer Drug Therapy Production Volume and Growth Rate of Targeted Therapy (2018-2023)
-
Figure China Cancer Drug Therapy Market Share by Application in 2018
-
Figure China Cancer Drug Therapy Market Share by Application in 2023
-
Figure China Cancer Drug Therapy Total Market Size and Growth Rate from Consumption End
-
Figure China Cancer Drug Therapy Market Size and Growth Rate of Angiogenesis Inhibitors (2018-2023)
-
Figure China Cancer Drug Therapy Market Size and Growth Rate of mTOR Inhibitors (2018-2023)
-
Figure China Cancer Drug Therapy Market Size and Growth Rate of Cytokine Immunotherapy (IL-2) (2018-2023)
-
Figure China Cancer Drug Therapy Market Size and Growth Rate of Monoclonal Antibodies (2018-2023)
-
Table China Cancer Drug Therapy Production Volume by Region (2018-2023)
-
Table China Cancer Drug Therapy Production Volume Share by Region (2018-2023)
-
Figure China Cancer Drug Therapy Production Volume Share by Region (2018-2023)
-
Table China Cancer Drug Therapy Production Value by Region (2018-2023)
-
Table China Cancer Drug Therapy Production Value Share by Region (2018-2023)
-
Figure China Cancer Drug Therapy Production Value Share by Region (2018-2023)
-
Table China Cancer Drug Therapy Sales Volume by Region (2018-2023)
-
Table China Cancer Drug Therapy Sales Volume Share by Region (2018-2023)
-
Figure China Cancer Drug Therapy Sales Volume Share by Region (2018-2023)
-
Table China Cancer Drug Therapy Sales Value by Region (2018-2023)
-
Table China Cancer Drug Therapy Sales Value Share by Region (2018-2023)
-
Figure China Cancer Drug Therapy Sales Value Share by Region (2018-2023)
-
Table North China Cancer Drug Therapy Production Volume by Type (2018-2023)
-
Table North China Cancer Drug Therapy Production Volume Share by Type (2018-2023)
-
Figure North China Cancer Drug Therapy Production Volume Share by Type (2018-2023)
-
Table North China Cancer Drug Therapy Sales Volume by Application (2018-2023)
-
Table North China Cancer Drug Therapy Sales Volume Share by Application (2018-2023)
-
Figure North China Cancer Drug Therapy Sales Volume Share by Application (2018-2023)
-
Table Central China Cancer Drug Therapy Production Volume by Type (2018-2023)
-
Table Central China Cancer Drug Therapy Production Volume Share by Type (2018-2023)
-
Figure Central China Cancer Drug Therapy Production Volume Share by Type (2018-2023)
-
Table Central China Cancer Drug Therapy Sales Volume by Application (2018-2023)
-
Table Central China Cancer Drug Therapy Sales Volume Share by Application (2018-2023)
-
Figure Central China Cancer Drug Therapy Sales Volume Share by Application (2018-2023)
-
Table South China Cancer Drug Therapy Production Volume by Type (2018-2023)
-
Table South China Cancer Drug Therapy Production Volume Share by Type (2018-2023)
-
Figure South China Cancer Drug Therapy Production Volume Share by Type (2018-2023)
-
Table South China Cancer Drug Therapy Sales Volume by Application (2018-2023)
-
Table South China Cancer Drug Therapy Sales Volume Share by Application (2018-2023)
-
Figure South China Cancer Drug Therapy Sales Volume Share by Application (2018-2023)
-
Table East China Cancer Drug Therapy Production Volume by Type (2018-2023)
-
Table East China Cancer Drug Therapy Production Volume Share by Type (2018-2023)
-
Figure East China Cancer Drug Therapy Production Volume Share by Type (2018-2023)
-
Table East China Cancer Drug Therapy Sales Volume by Application (2018-2023)
-
Table East China Cancer Drug Therapy Sales Volume Share by Application (2018-2023)
-
Figure East China Cancer Drug Therapy Sales Volume Share by Application (2018-2023)
-
Table Northeast China Cancer Drug Therapy Production Volume by Type (2018-2023)
-
Table Northeast China Cancer Drug Therapy Production Volume Share by Type (2018-2023)
-
Figure Northeast China Cancer Drug Therapy Production Volume Share by Type (2018-2023)
-
Table Northeast China Cancer Drug Therapy Sales Volume by Application (2018-2023)
-
Table Northeast China Cancer Drug Therapy Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Cancer Drug Therapy Sales Volume Share by Application (2018-2023)
-
Table Southwest China Cancer Drug Therapy Production Volume by Type (2018-2023)
-
Table Southwest China Cancer Drug Therapy Production Volume Share by Type (2018-2023)
-
Figure Southwest China Cancer Drug Therapy Production Volume Share by Type (2018-2023)
-
Table Southwest China Cancer Drug Therapy Sales Volume by Application (2018-2023)
-
Table Southwest China Cancer Drug Therapy Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Cancer Drug Therapy Sales Volume Share by Application (2018-2023)
-
Table Northwest China Cancer Drug Therapy Production Volume by Type (2018-2023)
-
Table Northwest China Cancer Drug Therapy Production Volume Share by Type (2018-2023)
-
Figure Northwest China Cancer Drug Therapy Production Volume Share by Type (2018-2023)
-
Table Northwest China Cancer Drug Therapy Sales Volume by Application (2018-2023)
-
Table Northwest China Cancer Drug Therapy Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Cancer Drug Therapy Sales Volume Share by Application (2018-2023)
-
Table Amgen / Allergan Company Profile
-
Table Amgen / Allergan Cancer Drug Therapy Revenue, Price and Gross (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer Cancer Drug Therapy Revenue, Price and Gross (2018-2023)
-
Table AstraZeneca Company Profile
-
Table AstraZeneca Cancer Drug Therapy Revenue, Price and Gross (2018-2023)
-
Table Incyte Company Profile
-
Table Incyte Cancer Drug Therapy Revenue, Price and Gross (2018-2023)
-
Table Roche Company Profile
-
Table Roche Cancer Drug Therapy Revenue, Price and Gross (2018-2023)
-
Table Bristol-Myers Squibb Company Profile
-
Table Bristol-Myers Squibb Cancer Drug Therapy Revenue, Price and Gross (2018-2023)
-
Table Exelixis Company Profile
-
Table Exelixis Cancer Drug Therapy Revenue, Price and Gross (2018-2023)
-
Table Aveo Pharmaceuticals Company Profile
-
Table Aveo Pharmaceuticals Cancer Drug Therapy Revenue, Price and Gross (2018-2023)
-
Table Novartis Company Profile
-
Table Novartis Cancer Drug Therapy Revenue, Price and Gross (2018-2023)
-
Table Bayer Company Profile
-
Table Bayer Cancer Drug Therapy Revenue, Price and Gross (2018-2023)
-
Table Merck Company Profile
-
Table Merck Cancer Drug Therapy Revenue, Price and Gross (2018-2023)
-
Table Argos Therapeutics Company Profile
-
Table Argos Therapeutics Cancer Drug Therapy Revenue, Price and Gross (2018-2023)
-
Table Genentech (Roche) Company Profile
-
Table Genentech (Roche) Cancer Drug Therapy Revenue, Price and Gross (2018-2023)
-
